Adjuvant therapies after curative treatments for hepatocellular carcinoma: Current status and prospects by Xiao-Dong Zhu, Kang-Shuai Li, Hui-Chuan Sun

Get full text

Targeting angiogenesis for liver cancer: Past, present, and future by Xiao-Dong Zhu, Zhao-You Tang, Hui-Chuan Sun

Get full text

The development and prospects of liver surgery by Hui-Chuan Sun, Ying-Hao Shen, Cheng Huang, Xiao-Dong Zhu, Chang-Jun Tan, Zhao-You Tang, Jia Fan, Jian Zhou

Get full text

Effectiveness and safety of lenvatinib plus anti‐programmed death‐1 antibodies in patients with hepatocellular carcinoma: A real‐world cohort study by Ming‐Hao Xu, Cheng Huang, Mei‐Ling Li, Xiao‐Dong Zhu, Chang‐Jun Tan, Jian Zhou, Jia Fan, Hui‐Chuan Sun, Ying‐Hao Shen

Get full text

Depth of radiographic response as an independent prognostic factor for patients with initially unresectable hepatocellular carcinoma receiving hepatectomy following targeted therap... by Bin Xu, Lu-Na Wang, Zi-Yi Wang, Tian He, Xiao-Dong Zhu, Ying-Hao Shen, Jian Zhou, Jia Fan, Hui-Chuan Sun, Cheng Huang

Get full text

Criteria for identifying potentially resectable patients with initially oncologically unresectable hepatocellular carcinoma before treatment with lenvatinib plus an anti–PD–1 antib... by Bin Xu, Xiao-Dong Zhu, Ying-Hao Shen, Jin-Jin Zhu, Jie Liu, Mei-Ling Li, Pei-Wen Tang, Jian Zhou, Jia Fan, Hui-Chuan Sun, Cheng Huang

Get full text

Sintilimab plus bevacizumab followed by resection in intermediate-stage hepatocellular carcinoma: a phase Ib clinical trial with biomarker analysis by Jia Fan, Shuang-Jian Qiu, Xiao-Ying Wang, Qiang Gao, Ying-Hong Shi, Yuan Ji, Cheng Huang, Hui-Chuan Sun, Xiao-Dong Zhu, Zi-Yi Wang, Ying-Hao Shen

Get full text

The Safety Profile of Hepatectomy Following Preoperative Systemic Therapy with Lenvatinib Plus Anti-PD-1 Antibodies Versus Hepatectomy Alone in Patients With Hepatocellular Carcino... by Ying-Hao Shen, MD, Cheng Huang, MD, Xiao-Dong Zhu, MD, Ming-Hao Xu, BS, Zhao-Shuo Chen, MS, Chang-Jun Tan, MD, Jian Zhou, MD, Jia Fan, MD, Hui-Chuan Sun, MD

Get full text

The prognostic value of systemic immune-inflammation index in patients with unresectable hepatocellular carcinoma treated with immune-based therapy by Tian He, Bin Xu, Lu-Na Wang, Zi-Yi Wang, Huan-Chen Shi, Cheng-Jie Zhong, Xiao-Dong Zhu, Ying-Hao Shen, Jian Zhou, Jia Fan, Hui-Chuan Sun, Bo Hu, Cheng Huang

Get full text

Suppression of natural killer cells by sorafenib contributes to prometastatic effects in hepatocellular carcinoma. by Qiang-Bo Zhang, Hui-Chuan Sun, Ke-Zhi Zhang, Qing-An Jia, Yang Bu, Miao Wang, Zong-Tao Chai, Quan-Bao Zhang, Wen-Quan Wang, Ling-Qun Kong, Xiao-dong Zhu, Lu Lu, Wei-Zhong Wu, Lu Wang, Zhao-You Tang

Get full text

The pattern of tumor progression on first-line immune checkpoint inhibitor-based systemic therapy for Chinese advanced hepatocellular carcinoma –CLEAP 004 study by Chao-Xu Yang, Yang-Xun Pan, Feng Ye, Xiao-Dong Zhu, Jun Xue, Xi Li, Zhen-Gang Yuan, Lan Zhang, Li Xu, Yong-Jun Chen, Nan-Ya Wang, Hui-Chuan Sun, Xiu-Feng Liu, China Liver Cancer Study Group Young Investigators (CLEAP)

Get full text

Proteomic and metabolomic features in patients with HCC responding to lenvatinib and anti-PD1 therapy by Zhong-Chen Li, Jie Wang, He-Bin Liu, Yi-Min Zheng, Jian-Hang Huang, Jia-Bin Cai, Lei Zhang, Xin Liu, Ling Du, Xue-Ting Yang, Xiao-Qiang Chai, Ying-Hua Jiang, Zheng-Gang Ren, Jian Zhou, Jia Fan, De-Cai Yu, Hui-Chuan Sun, Cheng Huang, Feng Liu

Get full text

miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a by Man-Qing Cao, A-Bin You, Xiao-Dong Zhu, Wei Zhang, Yuan-Yuan Zhang, Shi-Zhe Zhang, Ke-wei Zhang, Hao Cai, Wen-Kai Shi, Xiao-Long Li, Kang-Shuai Li, Dong-Mei Gao, De-Ning Ma, Bo-Gen Ye, Cheng-Hao Wang, Cheng-Dong Qin, Hui-Chuan Sun, Ti Zhang, Zhao-You Tang

Get full text

Toripalimab combined with lenvatinib and GEMOX is a promising regimen as first-line treatment for advanced intrahepatic cholangiocarcinoma: a single-center, single-arm, phase 2 stu... by Guo-Ming Shi, Xiao-Yong Huang, Dong Wu, Hui-Chuan Sun, Fei Liang, Yuan Ji, Yi Chen, Guo-Huan Yang, Jia-Cheng Lu, Xian-Long Meng, Xin-Ying Wang, Lei Sun, Ning-Ling Ge, Xiao-Wu Huang, Shuang-Jian Qiu, Xin-Rong Yang, Qiang Gao, Yi-Feng He, Yang Xu, Jian Sun, Zheng-Gang Ren, Jia Fan, Jian Zhou

Get full text

Radiographic and α-fetoprotein response predict pathologic complete response to immunotherapy plus a TKI in hepatocellular carcinoma: a multicenter study by Cheng Huang, Xiao-Dong Zhu, Ying-Hao Shen, Bin Xu, Dong Wu, Yuan Ji, Ling-Li Chen, Tian-Qiang Song, Wei Zhang, Zhi-Ming Zeng, Hua-Sheng Huang, Kui Wang, Lan-Qing Huang, Yong-Jun Chen, Yu-Chen Yang, Le-Du Zhou, Guo Long, Hai-Tao Zhao, Yun-Chao Wang, Ning-Ling Ge, Yi Chen, Chang-Jun Tan, Jian Zhou, Jia Fan, Hui-Chuan Sun

Get full text

Tumor radiomic features on pretreatment MRI to predict response to lenvatinib plus an anti–PD-1 antibody in advanced hepatocellular carcinoma: a multicenter study by Bin Xu, Sanyuan Dong, Xue-Li Bai, Tian-Qiang Song, Bo-Heng Zhang, Le-Du Zhou, Yong-Jun Chen, Zhi-Ming Zeng, Kui Wang, Hai-Tao Zhao, Na Lu, Wei Zhang, Xu-Bin Li, Su-Su Zheng, Guo Long, Yu-Chen Yang, Hua-Sheng Huang, Lan-Qing Huang, Yun-Chao Wang, Fei Liang, Xiao-Dong Zhu, Cheng Huang, Ying-Hao Shen, Jian Zhou, Meng-Su Zeng, Jia Fan, Sheng-Xiang Rao, Hui-Chuan Sun

Get full text

Chinese Expert Consensus on Immunotherapy for Hepatocellular Carcinoma (2021 edition) by Yu Yang, Juxian Sun, Mengchao Wu, Wan Yee Lau, Shusen Zheng, Xue-Hao Wang, Xiaoping Chen, Jia Fan, Jiahong Dong, Jianqiang Cai, Minshan Chen, Yongjun Chen, Zhangjun Cheng, Chaoliu Dai, Jianzhen Shan, Cheng-You Du, Chihua Fang, Heping Hu, Zhili Ji, Weidong Jia, Gong Li, Jing Li, Jiangtao Li, Chang Liu, Fubao Liu, Yong Ma, Yilei Mao, Zuoxing Niu, Jie Shen, Jie Shi, Xuetao Shi, Wenjie Song, Hui-Chuan Sun, Guang Tan, Ran Tao, Xiaohu Wang, Tianfu Wen, Liqun Wu, Jinglin Xia, Bang-De Xiang, Maolin Yan, Mingang Ying, Ling Zhang, Xuewen Zhang, Zhao Chong Zeng, Yubao Zhang, Zhiwei Zhang, Jie Zhou, Cuncai Zhou, Jun Zhou, Ledu Zhou, Xinmin Zhou, Ji Zhu, Zhenyu Zhu, Qi Zhang, Qiu Li, Shuqun Cheng

Get full text